Correlation Between Estrella Immunopharma and Lantern Pharma
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Lantern Pharma, you can compare the effects of market volatilities on Estrella Immunopharma and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Lantern Pharma.
Diversification Opportunities for Estrella Immunopharma and Lantern Pharma
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Estrella and Lantern is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Lantern Pharma go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and Lantern Pharma
Assuming the 90 days horizon Estrella Immunopharma is expected to under-perform the Lantern Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Estrella Immunopharma is 7.64 times less risky than Lantern Pharma. The stock trades about -0.58 of its potential returns per unit of risk. The Lantern Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 313.00 in Lantern Pharma on September 1, 2024 and sell it today you would earn a total of 8.00 from holding Lantern Pharma or generate 2.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 14.29% |
| Values | Daily Returns |
Estrella Immunopharma vs. Lantern Pharma
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Lantern Pharma |
Estrella Immunopharma and Lantern Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and Lantern Pharma
The main advantage of trading using opposite Estrella Immunopharma and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.| Estrella Immunopharma vs. Tff Pharmaceuticals | Estrella Immunopharma vs. Eliem Therapeutics | Estrella Immunopharma vs. Inhibrx | Estrella Immunopharma vs. Enliven Therapeutics |
| Lantern Pharma vs. Tff Pharmaceuticals | Lantern Pharma vs. Eliem Therapeutics | Lantern Pharma vs. Inhibrx | Lantern Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |